Publications
51
Citations
4,104
Est. group size
—
Recurring co-author estimate
Active years
23
Publishing since 2003
Christine H. Lee's research focuses on Clostridioides difficile infection and its treatment through fecal microbiota transplantation (FMT) and other microbiota-based therapies. Her work includes clinical trials of microbiome-restoring drugs, methods for detecting microbial engraftment after treatment, and studies of gut microbiota diversity using metagenomic and culture-based techniques. This work spans clinical infectious disease research, microbiome science, and applied data analysis methods for studying microbial communities.
Publication output has been modest and fluctuating over the last decade, with occasional gaps (e.g., 2021) and an average of about one publication per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Detecting microbial engraftment after FMT using placebo sequencing and culture enriched metagenomics to sort signals from noise
Nature Communications · 2025
- Detecting microbial engraftment after FMT: sorting signals from noise using placebo sequencing and culture-enriched metagenomics
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Prevalence of Comorbid Factors in Patients With Recurrent <i>Clostridioides difficile</i> Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota–Based Therapeutic
Clinical Infectious Diseases · 2023
- Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial
BMC Infectious Diseases · 2022
- Topological Data Analysis of Clostridioides difficile Infection and Fecal Microbiota Transplantation
Emerging topics in statistics and biostatistics · 2020
- Precision medicine and gut dysbiosis
Healthcare Management Forum · 2020
- Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure
European Journal of Clinical Microbiology & Infectious Diseases · 2019
- Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660—A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection
Clinical Infectious Diseases · 2018
- Building an Adult Congenital Heart Program: Critical Components and Important Allies
Current Cardiology Reports · 2018
- Probing the geometry of data with diffusion Fréchet functions
Applied and Computational Harmonic Analysis · 2018
- Infections in General Surgery
2018
- Detection of DNA Amplicons of Polymerase Chain Reaction Using Litmus Test
Scientific Reports · 2017
- Topological Data Analysis of Clostridioides difficile Infection and Fecal Microbiota Transplantation
arXiv (Cornell University) · 2017
- Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent <i>Clostridium difficile</i> Infection
JAMA · 2016
- Capturing the diversity of the human gut microbiota through culture-enriched molecular profiling
Genome Medicine · 2016
- arXiv (Cornell University)×3
- Clinical Infectious Diseases×2
- Gastroenterology×2
- JAMA×1
- Genome Medicine×1
- Huiping Xu
Medicine · Indiana University
- Monika Fischer
Medicine · Indiana University
- Paul Oladele
Medicine · Purdue University West Lafayette
- Olivia Coughlin
Medicine · Indiana University
- Ahmed AbdelKhalek
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile